Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE.
Journal: Diabetes, obesity & metabolism
Published: March 11, 2020
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
Journal: Diabetes, obesity & metabolism
Published: March 11, 2020
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).
Journal: Diabetes, obesity & metabolism
Published: December 31, 2018
Redefining Hypoglycemia in Clinical Trials: Validation of Definitions Recently Adopted by the American Diabetes Association/European Association for the Study of Diabetes.
Journal: Diabetes care
Published: November 13, 2018
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
Journal: Diabetes, obesity & metabolism
Published: November 13, 2018
Concentrations of Intact Insulin Concurs With FDA and EMA Standards When Measured by HPLC in Different Parts of the Distribution Cold Chain.
Journal: Journal of diabetes science and technology
Published: June 29, 2018
Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events).
Journal: Therapeutic innovation & regulatory science
Published: May 26, 2018
Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus.
Journal: JACC. Heart failure
Published: November 27, 2017
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Journal: Diabetologia
Published: July 21, 2017
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Journal: The New England journal of medicine
Published: June 13, 2017
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.
Journal: Diabetes, obesity & metabolism
Published: October 14, 2014
Last Updated: 09/26/2026